Disease Modification in Multiple Sclerosis by Flupirtine—Results of a Randomized Placebo Controlled Phase II Trial

Overview of attention for article published in Frontiers in Neurology, October 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 60,293 followers.

RT @NatRevNeurol: Disease Modification in Multiple Sclerosis by Flupirtine—Results of a Randomized Placebo Controlled Phase II Trial https:…

Disease Modification in Multiple Sclerosis by Flupirtine—Results of a Randomized Placebo Controlled Phase II Trial https://t.co/O2Kp74Ap8d

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.